Impact of Tourniquet Use on Cefazolin Efficacy in Total Knee Arthroplasty
|
Reviewed & Translated by Dat Tien Nguyen, B.A, ScM.
|
Posted on September 30th, 2024
|
Surgical site infections are a significant complication often seen in patients undergoing total knee arthroplasty. To prevent infections caused by bacterial pathogens such as Staphylococcus and Streptococcus, cefazolin is commonly administered intravenously before surgery. However, the use of a tourniquet, which helps improve bone cementing during the procedure, can restrict blood flow and potentially reduce the effectiveness of antibiotic prophylaxis. To investigate the impact of tourniquet application on the efficacy of antibiotics, a team of researchers from McGill University conducted a study.
The clinical trial involved 59 patients, with an average age of around 60, who underwent total knee arthroplasty. Each participant received a 2-gram dose of cefazolin intravenously within one hour before the surgery. Half of the patients were randomly assigned to have a tourniquet applied at a pressure of 250 mmHg. Results showed that cefazolin concentrations were higher in the serum compared to the synovium, bone, and fat tissues. Importantly, the use of the tourniquet significantly lowered cefazolin levels in local tissues, dropping them below the minimum inhibitory concentration for many pathogens. The authors noted that tourniquet use might increase the risk of surgical site infections and recommended limiting its use to the cementing of the implant. Additionally, they observed that cefazolin concentrations decreased significantly after the first hour, suggesting that an additional dose should be administered to maintain adequate antibiotic levels throughout the procedure.
The clinical trial involved 59 patients, with an average age of around 60, who underwent total knee arthroplasty. Each participant received a 2-gram dose of cefazolin intravenously within one hour before the surgery. Half of the patients were randomly assigned to have a tourniquet applied at a pressure of 250 mmHg. Results showed that cefazolin concentrations were higher in the serum compared to the synovium, bone, and fat tissues. Importantly, the use of the tourniquet significantly lowered cefazolin levels in local tissues, dropping them below the minimum inhibitory concentration for many pathogens. The authors noted that tourniquet use might increase the risk of surgical site infections and recommended limiting its use to the cementing of the implant. Additionally, they observed that cefazolin concentrations decreased significantly after the first hour, suggesting that an additional dose should be administered to maintain adequate antibiotic levels throughout the procedure.